NCT04892927

Brief Summary

GMG ArcData will create a mobile-based application to improve communications and data exchange among patients and navigators involved in new pancreas surgery oncology episodes of care. Functionality will align with care processes using smartphone and the EHR patient portal. GMG will apply user-centered design theory and behavioral psychology approaches to co-design, develop, and test usability of features that optimize patient navigators-patient encounters on scheduling issues, nutrition guidance, pain management, wellbeing assessments, and activity tracking. Evaluation endpoints will reflect how the application improves the efficiency of workflows and lessens cognitive burden. Study will assess how patients and navigators perceive the tool's ability to provide more control and easier access to information about surgical care. The key project innovations are based on Fast Healthcare Interoperability Resources (FHIR)-based engineering standards that enable interoperability among digital health platforms, apply 'recommender' functions based on similar patients' experiences, and exploit microeducation tools to enhance patient understanding about their surgical care. The research team has partnered with MedStar Health and Georgetown University Lombardi Comprehensive Cancer Center to co-design the software and access patients for usability testing. Successful implementation will lead to exploring a joint venture for scaling to other care episodes, expanded functionality, and co-creating business models for commercialization.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 2, 2021

Completed
1 day until next milestone

Study Start

First participant enrolled

May 3, 2021

Completed
16 days until next milestone

First Posted

Study publicly available on registry

May 19, 2021

Completed
7 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 26, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2021

Completed
Last Updated

May 19, 2021

Status Verified

May 1, 2021

Enrollment Period

23 days

First QC Date

May 2, 2021

Last Update Submit

May 14, 2021

Conditions

Outcome Measures

Primary Outcomes (5)

  • Patient Anxiety and Cognitive Burden

    Patient Health Questionnaire-2 (PHQ-2)

    Up to 24 weeks

  • Patient Anxiety and Cognitive Burden

    Patient Health Questionnaire-9 (PHQ-9)

    Up to 24 weeks

  • Time Burden

    Duration of task completion -- data within the app (time stamps)

    Through study completion, an average of 6 weeks

  • Improved information sharing

    Presence/absence of critical information in app (e.g., imaging)

    Through study completion, an average of 8 weeks

  • Improved information sharing

    Navigator perception via survey feedback

    Through study completion, an average of 8 weeks

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Pancreas cancer patients and other surgical candidates for procedures including pancreatectomy, whipple procedure.

You may qualify if:

  • Hepatobiliary surgery patients seeking care at research location
  • A sufficient level of comfort with personal computers or smart phone devices

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MedStar Georgetown University Hospital

Washington D.C., District of Columbia, 20007, United States

RECRUITING

MeSH Terms

Conditions

Pancreatic NeoplasmsPatient Participation

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System DiseasesPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Gregory Downing

    GMG Arcdata LLC

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
4 Weeks
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2021

First Posted

May 19, 2021

Study Start

May 3, 2021

Primary Completion

May 26, 2021

Study Completion

June 30, 2021

Last Updated

May 19, 2021

Record last verified: 2021-05

Locations